Paris-based Klineo has raised 2mn for itsAIplatform that facilitates access to cancer clinical trials.
Klineos platform connects doctors and patients directly with relevant clinical trials.
The startups solution currently covers trials on skin cancer, breast cancer, and lymphoma.
Klineo was founded in 2021 by oncologist Dr Arnaud Bayle and two engineers, Thomas Peyresblanques and Nicolas Drizard.
It’s free, every week, in your inbox.
At the same time, approximately20% of clinical trials failbecause of insufficient participation.
The startup will also increase its team and improve its platform.
One of the themes of this years TNW Conference is Venture: Show Me The Money.
Story byIoanna Lykiardopoulou
Ioanna is a writer at TNW.
With a background in the humanities, she has a soft spot for social impact-enabling technologies.
